Two Sigma Advisers’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
|
|||||
|
2025
Q1 | $3.64M | Sell |
|
|||||
|
2024
Q4 | $7.96M | Buy |
|
|||||
|
2024
Q3 | $5.94M | Sell |
|
|||||
|
2024
Q2 | $8.6M | Buy |
|
|||||
|
2024
Q1 | $9.57M | Buy |
|
|||||
|
2023
Q4 | $6.42M | Buy |
|
|||||
|
2023
Q3 | $1.51M | Buy |
|
|||||
|
2023
Q2 | $952K | Sell |
|
|||||
|
2023
Q1 | $1.36M | Sell |
|
|||||
|
2022
Q4 | $8.82M | Buy |
|
|||||
|
2022
Q3 | $7.26M | Buy |
|
|||||
|
2022
Q2 | $85K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.14M | Sell |
|
|||||
|
2019
Q2 | $7.16M | Buy |
|
|||||
|
2019
Q1 | $2.71M | Buy |
|
|||||
|
2018
Q4 | $2.15M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.54M | Sell |
|
|||||
|
2017
Q4 | $1.58M | Buy |
|
|||||
|
2017
Q3 | $742K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $5.21M | Buy |
|
|||||
|
2015
Q1 | $2.07M | Buy |
|